VERSANT VENTURE MANAGEMENT, LLC Holdings
VERSANT VENTURE MANAGEMENT, LLC is an investment fund managing more than 58.66M US dollars. The largest holdings include CRISPR Therapeutics AG, Gritstone bio and Passage Bio. In Q4 2021 the fund bought assets of total value of 8.6M US dollars and sold assets of total value of 9.52M US dollars.
VERSANT VENTURE MANAGEMENT, LLC portfolio value:
VERSANT VENTURE MANAGEMENT, LLC quarter portfolio value change:
VERSANT VENTURE MANAGEMENT, LLC 1 year portfolio value change:
VERSANT VENTURE MANAGEMENT, LLC 3 years portfolio value change:
VERSANT VENTURE MANAGEMENT, LLC 5 years portfolio value change:
VERSANT VENTURE MANAGEMENT, LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q3 2016 | 48917910 | 72740790 |
| Q1 2017 | 8373843 | 2449980 |
| Q2 2018 | 181857 | 1506114 |
| Q1 2019 | 48664749 | 2784131 |
| Q2 2019 | 34566629 | 43244832 |
| Q1 2020 | 127071962 | 2777399 |
| Q2 2020 | 116280429 | 202075174 |
| Q3 2020 | 40001000 | 72449564 |
| Q4 2020 | 300957000 | 119270000 |
| Q1 2021 | 82428000 | 542353000 |
| Q4 2021 | 8603000 | 9523000 |
VERSANT VENTURE MANAGEMENT, LLC 13F holdings
| Stock |
|---|
| Portfolio share: 55.55% Portfolio value: 32.58M Avg. open price: $28.57 Current price: $52.11 P/L: +82.39% Sold -1.97% shares Q3 2021 |
| Portfolio share: 15.60% Portfolio value: 9.15M Avg. open price: $2.65 Current price: $2.87 P/L: +8.30% Sold -11.10% shares Q4 2021 |
| Portfolio share: 10.57% Portfolio value: 6.2M Avg. open price: N/A Current price: $1.16 P/L: N/A N/A Q1 2021 |
| Portfolio share: 8.21% Portfolio value: 4.81M Avg. open price: $10.84 Current price: $0.66 P/L: -93.91% Bought +1.29% shares Q1 2021 |
| Portfolio share: 4.35% Portfolio value: 2.55M Avg. open price: N/A Current price: $0.97 P/L: N/A Sold -29.52% shares Q2 2021 |
| Portfolio share: 3.24% Portfolio value: 1.90M Avg. open price: $13.42 Current price: $4.17 P/L: -68.93% Sold -49.87% shares Q2 2019 |
| Portfolio share: 2.27% Portfolio value: 1.33M Avg. open price: N/A Current price: $0.18 P/L: N/A N/A Q4 2021 |
| Portfolio share: 0.21% Portfolio value: 121K Avg. open price: N/A Current price: $0.29 P/L: N/A Sold -75.00% shares Q2 2017 |
Showing TOP 8 VERSANT VENTURE MANAGEMENT's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of VERSANT VENTURE MANAGEMENT, LLC?
The biggest position of the VERSANT VENTURE MANAGEMENT, LLC is CRISPR Therapeutics AG (CRSP) with 55.55% portfolio share worth of 32.58M US dollars.
Top 5 VERSANT VENTURE MANAGEMENT's holdings represent 94.28% of the portfolio:
- CRISPR Therapeutics AG (CRSP) – 55.55%
- Gritstone bio, Inc. (GRTS) – 15.6%
- Passage Bio, Inc. (PASG) – 10.57%
- Adverum Biotechnologies, Inc. (ADVM) – 8.21%
- Aligos Therapeutics, Inc. (ALGS) – 4.35%
Who is the portfolio manager of VERSANT VENTURE MANAGEMENT, LLC?
The portfolio manager of the VERSANT VENTURE MANAGEMENT, LLC is .
What is the total asset value of the VERSANT VENTURE MANAGEMENT, LLC portfolio?
VERSANT VENTURE MANAGEMENT, LLC total asset value (portfolio value) is 58.66M US dollars.
Who is ?
is the portfolio manager of the VERSANT VENTURE MANAGEMENT, LLC.
What is (VERSANT VENTURE MANAGEMENT, LLC) fund performance?
VERSANT VENTURE MANAGEMENT's quarterly performance is -10.08%, annualy -64.17%. In the past 3 years, the value of 's portfolio has increased by +71%. In the past 5 years, the value of the portfolio has increased by +148%.
What is the VERSANT VENTURE MANAGEMENT, LLC CIK?
VERSANT VENTURE MANAGEMENT's Central Index Key is 0001560009 .